Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results (Q43480992)

23 November 2017

Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results (English)

1 reference

23 November 2017

3

1 reference

23 November 2017

Eva Corpeleijn

2

0 references

author name string

Marco Mensink

1

1 reference

23 November 2017

Margriet Kruijshoop

4

1 reference

23 November 2017

Wim H M Saris

5

1 reference

23 November 2017

Tjerk W A de Bruin

6

1 reference

23 November 2017

Ellen E Blaak

7

1 reference

23 November 2017

1 July 2003

1 reference

Diabetes Research and Clinical Practice

23 November 2017

1 reference

23 November 2017

61

1 reference

23 November 2017

1

1 reference

23 November 2017

49-58

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Can Life-styles of Subjects With Impaired Glucose Tolerance Be Changed? A Feasibility Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Parental history of diabetes modifies the association between abdominal adiposity and hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Long-term and recent time trends in the prevalence of obesity among Dutch men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Moderate leisure-time physical activity: who is meeting the public health recommendations? A national cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900067-6

7 January 2021

10.1016/S0168-8227(03)00067-6

Identifiers

DOI

1 reference

23 November 2017

1 reference